C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 519/00 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2091057
2091057 9204354 PCTABS00011 Platelet activating factor antagonists of formula (I), wherein R1 is H or C1-C4 alkyl optionally substituted by a substituent selected from phenyl, halophenyl, pyridyl, (C1-C4 alkoxy) carbonyl and di-(C1-C4 alkyl) amino, or is C2-C4 alkyl substituted by hydroxyl or by one ore two C1-C4 alkoxy groups or is (CH2)nCONR7R8 where n is an integer from 1 to 4 and R7 and R8 are each independently H or C1-C4 alkyl, R2 is selected from H, OH and C1-C4 alkyl, R3 is selected from halo and C1-C4 alkyl, R4 is methyl, and p is an integer from 0 to 3 and m is an integer from 0 to 3; or a pharmaceutically acceptable salt thereof.
Cooper Kelvin
Fray Michael J.
Steele John
Cooper Kelvin
Fray Michael J.
Limited Pfizer
Pfizer Inc.
Smart & Biggar
LandOfFree
Substituted 6,7-dihydroimidazo(1,5,4-ef) (1,5)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 6,7-dihydroimidazo(1,5,4-ef) (1,5)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 6,7-dihydroimidazo(1,5,4-ef) (1,5)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1360043